A Phase 1b, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Vincristine and Dexamethasone in Adult Subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

UCI-16-10
NCT02404220
Cancer - Lymphoid Leukemia
Susan O'Brien
Open
Treatment
Dexamethasone, Entospletinib GS‐9973, Oncovin, Vincristine
Ib/II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.